Logo image of ATC

ATOTECH LTD (ATC) Stock Fundamental Analysis

USA - NYSE:ATC - JE00BMVMZ478 - Common Stock

22.71 USD
-0.03 (-0.13%)
Last: 8/16/2022, 8:17:26 PM
22.71 USD
0 (0%)
After Hours: 8/16/2022, 8:17:26 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ATC. ATC was compared to 83 industry peers in the Chemicals industry. ATC may be in some trouble as it scores bad on both profitability and health. ATC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ATC had positive earnings in the past year.
ATC Yearly Net Income VS EBIT VS OCF VS FCFATC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 100M -100M 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA 3.66%
ROE 13.66%
ROIC 6.7%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATC Yearly ROA, ROE, ROICATC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -20 -40

1.3 Margins

Industry RankSector Rank
OM 16.64%
PM (TTM) 8.44%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATC Yearly Profit, Operating, Gross MarginsATC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ATC is destroying value.
ATC has about the same amout of shares outstanding than it did 1 year ago.
ATC has a better debt/assets ratio than last year.
ATC Yearly Shares OutstandingATC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 50M 100M 150M
ATC Yearly Total Debt VS Total AssetsATC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 1B 2B 3B

2.2 Solvency

ATC has a Debt/Equity ratio of 1.70. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.95
WACC7.08%
ATC Yearly LT Debt VS Equity VS FCFATC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.85 indicates that ATC should not have too much problems paying its short term obligations.
A Quick Ratio of 1.44 indicates that ATC should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.44
ATC Yearly Current Assets VS Current LiabilitesATC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 135.00% over the past year.
The earnings per share for ATC have been decreasing by -46.07% on average. This is quite bad
The Revenue has decreased by -5.25% in the past year.
ATC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.93% yearly.
EPS 1Y (TTM)135%
EPS 3Y1.92%
EPS 5Y-46.07%
EPS Q2Q%143.64%
Revenue 1Y (TTM)-5.25%
Revenue growth 3Y7.32%
Revenue growth 5Y5.93%
Sales Q2Q%1.39%

3.2 Future

ATC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 87.84% yearly.
The Revenue is expected to grow by 6.63% on average over the next years.
EPS Next Y759.87%
EPS Next 2Y208.24%
EPS Next 3Y139.76%
EPS Next 5Y87.84%
Revenue Next Year4.86%
Revenue Next 2Y5.72%
Revenue Next 3Y6.5%
Revenue Next 5Y6.63%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ATC Yearly Revenue VS EstimatesATC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
ATC Yearly EPS VS EstimatesATC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 35.48 indicates a quite expensive valuation of ATC.
Compared to an average S&P500 Price/Earnings ratio of 27.69, ATC is valued a bit more expensive.
ATC is valuated rather expensively with a Price/Forward Earnings ratio of 20.18.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, ATC is valued at the same level.
Industry RankSector Rank
PE 35.48
Fwd PE 20.18
ATC Price Earnings VS Forward Price EarningsATC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.15
ATC Per share dataATC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

ATC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ATC's earnings are expected to grow with 139.76% in the coming years.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y208.24%
EPS Next 3Y139.76%

0

5. Dividend

5.1 Amount

ATC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ATOTECH LTD

NYSE:ATC (8/16/2022, 8:17:26 PM)

After market: 22.71 0 (0%)

22.71

-0.03 (-0.13%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-09 2022-08-09
Earnings (Next)N/A N/A
Inst Owners0.05%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.42B
Analysts48.33
Price Target25.3 (11.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 35.48
Fwd PE 20.18
P/S 2.94
P/FCF N/A
P/OCF N/A
P/B 4.76
P/tB N/A
EV/EBITDA 13.15
EPS(TTM)0.64
EY2.82%
EPS(NY)1.13
Fwd EY4.95%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.72
BVpS4.77
TBVpSN/A
PEG (NY)0.05
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 13.66%
ROCE N/A
ROIC 6.7%
ROICexc N/A
ROICexgc 22.84%
OM 16.64%
PM (TTM) 8.44%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.44
Altman-Z N/A
F-Score6
WACC7.08%
ROIC/WACC0.95
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)135%
EPS 3Y1.92%
EPS 5Y-46.07%
EPS Q2Q%143.64%
EPS Next Y759.87%
EPS Next 2Y208.24%
EPS Next 3Y139.76%
EPS Next 5Y87.84%
Revenue 1Y (TTM)-5.25%
Revenue growth 3Y7.32%
Revenue growth 5Y5.93%
Sales Q2Q%1.39%
Revenue Next Year4.86%
Revenue Next 2Y5.72%
Revenue Next 3Y6.5%
Revenue Next 5Y6.63%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A